Dr Zhang on the Potential Use of RNA Sequencing to Improve Treatment Selection in Advanced RCC
Tian Zhang, MD, MHS, discusses whether the use of RNA sequencing to identify biologic cluster assignment could improve first-line treatment selection in metastatic renal cell carcinoma.
Source: onclive.com